For more information visit: https://www.prnewswire.com/news-releases/bambusa-therapeutics-inc-announces-successful-series-seed-funding-to-advance-innovative-bispecific-antibodies-for-immunology–inflammation-302241958.html?tc=eml_cleartime
Select Page
Start Bambusa Therapeutics successfully closes Series Seed